KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aquestive Therapeutics (AQST) Debt Ratio (2017 - 2025)

Historic Debt Ratio for Aquestive Therapeutics (AQST) over the last 9 years, with Q3 2025 value amounting to 0.22.

  • Aquestive Therapeutics' Debt Ratio fell 2204.84% to 0.22 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.22, marking a year-over-year decrease of 2204.84%. This contributed to the annual value of 0.32 for FY2024, which is 3311.45% down from last year.
  • Per Aquestive Therapeutics' latest filing, its Debt Ratio stood at 0.22 for Q3 2025, which was down 2204.84% from 0.37 recorded in Q2 2025.
  • Over the past 5 years, Aquestive Therapeutics' Debt Ratio peaked at 1.02 during Q3 2022, and registered a low of 0.22 during Q3 2025.
  • Over the past 5 years, Aquestive Therapeutics' median Debt Ratio value was 0.61 (recorded in 2021), while the average stood at 0.58.
  • In the last 5 years, Aquestive Therapeutics' Debt Ratio surged by 6491.33% in 2022 and then crashed by 6787.42% in 2024.
  • Aquestive Therapeutics' Debt Ratio (Quarter) stood at 0.86 in 2021, then increased by 5.73% to 0.91 in 2022, then crashed by 47.53% to 0.48 in 2023, then crashed by 33.11% to 0.32 in 2024, then tumbled by 30.86% to 0.22 in 2025.
  • Its Debt Ratio stands at 0.22 for Q3 2025, versus 0.37 for Q2 2025 and 0.33 for Q1 2025.